Jefferies Lowers PT on Watson Pharmaceuticals to $60

Symbols: WPI
Share

Jefferies & Company has lowered the price target on Watson Pharmaceuticals (NYSE: WPI) from $70 to $60 and maintains its Hold rating.


 
 
< Previous
UPDATE: Citigroup Raises Target on Quest Diagnostics to $62
Next >
Sterne Agee Maintains Neutral on Commerce Bancshares
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust